The Patent Finder

Renovis, Inc.

Also on record
Records under this name other than patents Renovis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Renovis, Inc.

PatentTitleStatus Expires Confidence
US 8,859,545Tetrahydronaphthyridine and Tetrahydropyrido[4,3-d]pyrimidine Compounds and Compositions Thereof Useful for the Treatment of Inflammatory and Respiratory Diseases
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,745,451TETRAHYDRONAPHTHYRIDINE AND TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE COMPOUNDS AND COMPOSITIONS THEREOF USEFUL IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NEUROLOGICAL AND INFLAMMATORY DISORDERS AND DYSFUNCTIONS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,093,265Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
Formerly held
Lapsed on the fee record
Ended Jan 10, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 10, 2024From the USPTO record
US 7,985,553Method for Isolating Cell Type-Specific Mrnas
Formerly held
Lapsed on the fee record
Ended Jul 26, 2023 · High confidence
Lapsed on the fee recordEnded Jul 26, 2023High confidence
US 8,513,485Non Human Transgenic Mammal Comprising a Transgene Comprising a Nucleotide Sequence Encoding a Ribosomal Protein Fused to a Peptide Tag
Formerly held
Term ended
Term ended Oct 29, 2022 · High confidence
Term endedTerm ended Oct 29, 2022High confidence
US 7,816,371Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
Formerly held
Lapsed on the fee record
Ended Oct 19, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 19, 2022From the USPTO record
US 8,779,144Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
Formerly held
Lapsed on the fee record
Ended Jul 15, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 15, 2022From the USPTO record
US 8,653,091Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof
Formerly held
Lapsed on the fee record
Ended Feb 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2022From the USPTO record
US 8,546,579Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
Formerly held
Lapsed on the fee record
Ended Oct 1, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 1, 2021From the USPTO record
US 8,076,3452-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
Formerly held
Lapsed on the fee record
Ended Dec 13, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2019From the USPTO record
10 of 63 patents shown.
Pro members see all 63.
Pro members: see all 63 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited